Kapvay

Hot Flashes, Smoke, clonidine suppression test + 15 more

Treatment

20 Active Studies for Kapvay

Treatment for

Hot Flashes

What is Kapvay

ClonidineThe Generic name of this drug

Treatment SummaryClonidine is a medication used to treat high blood pressure, severe pain, and Attention Deficit Hyperactivity Disorder (ADHD). It works by activating alpha-2 adrenoceptors in the body. Clonidine was approved by the FDA in 1974 and has been commonly prescribed ever since.

Catapresis the brand name

image of different drug pills on a surface

Kapvay Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Catapres

Clonidine

1974

447

Effectiveness

How Kapvay Affects PatientsClonidine works by activating certain receptors in the body, which can reduce blood pressure, make you sleepy, and decrease electrical activity in the nerves. The amount of clonidine needed for it to be effective varies from person to person, and it is typically taken twice a day. The usual recommended dose is between 0.1mg to 2.4mg daily.

How Kapvay works in the bodyClonidine works by binding to the Alpha-2 adrenoceptor, a G-protein found in the brain. This binding causes a change in the G-protein's structure, allowing it to interact with an effector. This process can cause decreased blood pressure, inhibited pain signals, and increased sleepiness. It can also affect regulators of blood pressure in certain areas of the brain.

When to interrupt dosage

The advised measure of Kapvay is contingent upon the diagnosed condition, including methadone, diabetic diarrhea and Hypertensive disease. The dosage fluctuates as per the administration technique (e.g. Oral or Tablet) provided in the table below.

Condition

Dosage

Administration

methadone

, 0.1 mg, 0.2 mg, 0.3 mg, 0.5 mg/mL, 0.1 mg/mL, 0.01 mg/hour, 0.02 mg/hour, 0.03 mg/hour, 0.09 mg/mL, 0.17 mg, 0.26 mg, 0.025 mg, 0.15 mg, 25.0 mg

, Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Transdermal, Patch, Patch - Transdermal, Patch, extended release, Patch, extended release - Transdermal, For suspension, extended release, For suspension, extended release - Oral, Epidural, Injection, solution - Epidural, Kit, Kit - Oral, Suspension, extended release, Suspension, extended release - Oral

diabetic diarrhea

, 0.1 mg, 0.2 mg, 0.3 mg, 0.5 mg/mL, 0.1 mg/mL, 0.01 mg/hour, 0.02 mg/hour, 0.03 mg/hour, 0.09 mg/mL, 0.17 mg, 0.26 mg, 0.025 mg, 0.15 mg, 25.0 mg

, Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Transdermal, Patch, Patch - Transdermal, Patch, extended release, Patch, extended release - Transdermal, For suspension, extended release, For suspension, extended release - Oral, Epidural, Injection, solution - Epidural, Kit, Kit - Oral, Suspension, extended release, Suspension, extended release - Oral

Pheochromocytomas

, 0.1 mg, 0.2 mg, 0.3 mg, 0.5 mg/mL, 0.1 mg/mL, 0.01 mg/hour, 0.02 mg/hour, 0.03 mg/hour, 0.09 mg/mL, 0.17 mg, 0.26 mg, 0.025 mg, 0.15 mg, 25.0 mg

, Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Transdermal, Patch, Patch - Transdermal, Patch, extended release, Patch, extended release - Transdermal, For suspension, extended release, For suspension, extended release - Oral, Epidural, Injection, solution - Epidural, Kit, Kit - Oral, Suspension, extended release, Suspension, extended release - Oral

Hot Flashes

, 0.1 mg, 0.2 mg, 0.3 mg, 0.5 mg/mL, 0.1 mg/mL, 0.01 mg/hour, 0.02 mg/hour, 0.03 mg/hour, 0.09 mg/mL, 0.17 mg, 0.26 mg, 0.025 mg, 0.15 mg, 25.0 mg

, Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Transdermal, Patch, Patch - Transdermal, Patch, extended release, Patch, extended release - Transdermal, For suspension, extended release, For suspension, extended release - Oral, Epidural, Injection, solution - Epidural, Kit, Kit - Oral, Suspension, extended release, Suspension, extended release - Oral

clonidine suppression test

, 0.1 mg, 0.2 mg, 0.3 mg, 0.5 mg/mL, 0.1 mg/mL, 0.01 mg/hour, 0.02 mg/hour, 0.03 mg/hour, 0.09 mg/mL, 0.17 mg, 0.26 mg, 0.025 mg, 0.15 mg, 25.0 mg

, Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Transdermal, Patch, Patch - Transdermal, Patch, extended release, Patch, extended release - Transdermal, For suspension, extended release, For suspension, extended release - Oral, Epidural, Injection, solution - Epidural, Kit, Kit - Oral, Suspension, extended release, Suspension, extended release - Oral

Hot flashes

, 0.1 mg, 0.2 mg, 0.3 mg, 0.5 mg/mL, 0.1 mg/mL, 0.01 mg/hour, 0.02 mg/hour, 0.03 mg/hour, 0.09 mg/mL, 0.17 mg, 0.26 mg, 0.025 mg, 0.15 mg, 25.0 mg

, Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Transdermal, Patch, Patch - Transdermal, Patch, extended release, Patch, extended release - Transdermal, For suspension, extended release, For suspension, extended release - Oral, Epidural, Injection, solution - Epidural, Kit, Kit - Oral, Suspension, extended release, Suspension, extended release - Oral

Cancer Pain

, 0.1 mg, 0.2 mg, 0.3 mg, 0.5 mg/mL, 0.1 mg/mL, 0.01 mg/hour, 0.02 mg/hour, 0.03 mg/hour, 0.09 mg/mL, 0.17 mg, 0.26 mg, 0.025 mg, 0.15 mg, 25.0 mg

, Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Transdermal, Patch, Patch - Transdermal, Patch, extended release, Patch, extended release - Transdermal, For suspension, extended release, For suspension, extended release - Oral, Epidural, Injection, solution - Epidural, Kit, Kit - Oral, Suspension, extended release, Suspension, extended release - Oral

growth hormone stimulation test

, 0.1 mg, 0.2 mg, 0.3 mg, 0.5 mg/mL, 0.1 mg/mL, 0.01 mg/hour, 0.02 mg/hour, 0.03 mg/hour, 0.09 mg/mL, 0.17 mg, 0.26 mg, 0.025 mg, 0.15 mg, 25.0 mg

, Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Transdermal, Patch, Patch - Transdermal, Patch, extended release, Patch, extended release - Transdermal, For suspension, extended release, For suspension, extended release - Oral, Epidural, Injection, solution - Epidural, Kit, Kit - Oral, Suspension, extended release, Suspension, extended release - Oral

Human Growth Hormone Deficiency

, 0.1 mg, 0.2 mg, 0.3 mg, 0.5 mg/mL, 0.1 mg/mL, 0.01 mg/hour, 0.02 mg/hour, 0.03 mg/hour, 0.09 mg/mL, 0.17 mg, 0.26 mg, 0.025 mg, 0.15 mg, 25.0 mg

, Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Transdermal, Patch, Patch - Transdermal, Patch, extended release, Patch, extended release - Transdermal, For suspension, extended release, For suspension, extended release - Oral, Epidural, Injection, solution - Epidural, Kit, Kit - Oral, Suspension, extended release, Suspension, extended release - Oral

Attention Deficit Hyperactivity Disorder

, 0.1 mg, 0.2 mg, 0.3 mg, 0.5 mg/mL, 0.1 mg/mL, 0.01 mg/hour, 0.02 mg/hour, 0.03 mg/hour, 0.09 mg/mL, 0.17 mg, 0.26 mg, 0.025 mg, 0.15 mg, 25.0 mg

, Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Transdermal, Patch, Patch - Transdermal, Patch, extended release, Patch, extended release - Transdermal, For suspension, extended release, For suspension, extended release - Oral, Epidural, Injection, solution - Epidural, Kit, Kit - Oral, Suspension, extended release, Suspension, extended release - Oral

Hypertensive disease

, 0.1 mg, 0.2 mg, 0.3 mg, 0.5 mg/mL, 0.1 mg/mL, 0.01 mg/hour, 0.02 mg/hour, 0.03 mg/hour, 0.09 mg/mL, 0.17 mg, 0.26 mg, 0.025 mg, 0.15 mg, 25.0 mg

, Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Transdermal, Patch, Patch - Transdermal, Patch, extended release, Patch, extended release - Transdermal, For suspension, extended release, For suspension, extended release - Oral, Epidural, Injection, solution - Epidural, Kit, Kit - Oral, Suspension, extended release, Suspension, extended release - Oral

Smoking Cessation

, 0.1 mg, 0.2 mg, 0.3 mg, 0.5 mg/mL, 0.1 mg/mL, 0.01 mg/hour, 0.02 mg/hour, 0.03 mg/hour, 0.09 mg/mL, 0.17 mg, 0.26 mg, 0.025 mg, 0.15 mg, 25.0 mg

, Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Transdermal, Patch, Patch - Transdermal, Patch, extended release, Patch, extended release - Transdermal, For suspension, extended release, For suspension, extended release - Oral, Epidural, Injection, solution - Epidural, Kit, Kit - Oral, Suspension, extended release, Suspension, extended release - Oral

Smoke

, 0.1 mg, 0.2 mg, 0.3 mg, 0.5 mg/mL, 0.1 mg/mL, 0.01 mg/hour, 0.02 mg/hour, 0.03 mg/hour, 0.09 mg/mL, 0.17 mg, 0.26 mg, 0.025 mg, 0.15 mg, 25.0 mg

, Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Transdermal, Patch, Patch - Transdermal, Patch, extended release, Patch, extended release - Transdermal, For suspension, extended release, For suspension, extended release - Oral, Epidural, Injection, solution - Epidural, Kit, Kit - Oral, Suspension, extended release, Suspension, extended release - Oral

Gilles de la Tourette's Syndrome

, 0.1 mg, 0.2 mg, 0.3 mg, 0.5 mg/mL, 0.1 mg/mL, 0.01 mg/hour, 0.02 mg/hour, 0.03 mg/hour, 0.09 mg/mL, 0.17 mg, 0.26 mg, 0.025 mg, 0.15 mg, 25.0 mg

, Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Transdermal, Patch, Patch - Transdermal, Patch, extended release, Patch, extended release - Transdermal, For suspension, extended release, For suspension, extended release - Oral, Epidural, Injection, solution - Epidural, Kit, Kit - Oral, Suspension, extended release, Suspension, extended release - Oral

clozapine

, 0.1 mg, 0.2 mg, 0.3 mg, 0.5 mg/mL, 0.1 mg/mL, 0.01 mg/hour, 0.02 mg/hour, 0.03 mg/hour, 0.09 mg/mL, 0.17 mg, 0.26 mg, 0.025 mg, 0.15 mg, 25.0 mg

, Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Transdermal, Patch, Patch - Transdermal, Patch, extended release, Patch, extended release - Transdermal, For suspension, extended release, For suspension, extended release - Oral, Epidural, Injection, solution - Epidural, Kit, Kit - Oral, Suspension, extended release, Suspension, extended release - Oral

Postherpetic Neuralgia

, 0.1 mg, 0.2 mg, 0.3 mg, 0.5 mg/mL, 0.1 mg/mL, 0.01 mg/hour, 0.02 mg/hour, 0.03 mg/hour, 0.09 mg/mL, 0.17 mg, 0.26 mg, 0.025 mg, 0.15 mg, 25.0 mg

, Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Transdermal, Patch, Patch - Transdermal, Patch, extended release, Patch, extended release - Transdermal, For suspension, extended release, For suspension, extended release - Oral, Epidural, Injection, solution - Epidural, Kit, Kit - Oral, Suspension, extended release, Suspension, extended release - Oral

Defiant Disorder, Oppositional

, 0.1 mg, 0.2 mg, 0.3 mg, 0.5 mg/mL, 0.1 mg/mL, 0.01 mg/hour, 0.02 mg/hour, 0.03 mg/hour, 0.09 mg/mL, 0.17 mg, 0.26 mg, 0.025 mg, 0.15 mg, 25.0 mg

, Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Transdermal, Patch, Patch - Transdermal, Patch, extended release, Patch, extended release - Transdermal, For suspension, extended release, For suspension, extended release - Oral, Epidural, Injection, solution - Epidural, Kit, Kit - Oral, Suspension, extended release, Suspension, extended release - Oral

Disease

, 0.1 mg, 0.2 mg, 0.3 mg, 0.5 mg/mL, 0.1 mg/mL, 0.01 mg/hour, 0.02 mg/hour, 0.03 mg/hour, 0.09 mg/mL, 0.17 mg, 0.26 mg, 0.025 mg, 0.15 mg, 25.0 mg

, Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Tablet, extended release, Tablet, extended release - Oral, Transdermal, Patch, Patch - Transdermal, Patch, extended release, Patch, extended release - Transdermal, For suspension, extended release, For suspension, extended release - Oral, Epidural, Injection, solution - Epidural, Kit, Kit - Oral, Suspension, extended release, Suspension, extended release - Oral

Warnings

Kapvay has five contraindications. It should not be consumed when experiencing any of the conditions enumerated in the following table.Kapvay Contraindications

Condition

Risk Level

Notes

Pulse Frequency

Do Not Combine

administration above the C4 dermatome

Do Not Combine

Communicable Diseases

Do Not Combine

bleeding diathesis

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Clonidine may interact with Pulse Frequency

There are 20 known major drug interactions with Kapvay.

Common Kapvay Drug Interactions

Drug Name

Risk Level

Description

1,2-Benzodiazepine

Major

The risk or severity of sedation can be increased when Clonidine is combined with 1,2-Benzodiazepine.

2,5-Dimethoxy-4-ethylthioamphetamine

Major

The risk or severity of sedation can be increased when Clonidine is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.

4-Bromo-2,5-dimethoxyamphetamine

Major

The risk or severity of sedation can be increased when Clonidine is combined with 4-Bromo-2,5-dimethoxyamphetamine.

4-Methoxyamphetamine

Major

The risk or severity of sedation can be increased when Clonidine is combined with 4-Methoxyamphetamine.

5-methoxy-N,N-dimethyltryptamine

Major

The risk or severity of sedation can be increased when Clonidine is combined with 5-methoxy-N,N-dimethyltryptamine.

Kapvay Toxicity & Overdose RiskThe lowest toxic dose of the drug in rats is 126mg/kg. For humans, the lowest toxic dose is 70µg/kg in children, 126µg/kg in women, and 69µg/kg in men. Symptoms of overdose include high or low blood pressure, slow heartbeat, shallow breathing, hypothermia, drowsiness, decreased reflexes, weakness, irritability, and pupil constriction. In severe cases, patients may experience cardiac problems, difficulty breathing, coma, or seizures. It is not recommended to induce vomiting, but gastric lavage or activated charcoal may be helpful if the

image of a doctor in a lab doing drug, clinical research

Kapvay Novel Uses: Which Conditions Have a Clinical Trial Featuring Kapvay?

231 active trials are being conducted to investigate the potential of Kapvay in aiding Smoking Cessation, managing Menopause symptoms and alleviating severe Cancer pain.

Condition

Clinical Trials

Trial Phases

Attention Deficit Hyperactivity Disorder

71 Actively Recruiting

Phase 4, Not Applicable, Phase 1, Phase 2, Phase 3, Early Phase 1

Cancer Pain

0 Actively Recruiting

Disease

9 Actively Recruiting

Phase 2, Phase 3, Not Applicable, Phase 1

growth hormone stimulation test

0 Actively Recruiting

Pheochromocytomas

0 Actively Recruiting

Smoke

0 Actively Recruiting

methadone

0 Actively Recruiting

diabetic diarrhea

0 Actively Recruiting

Postherpetic Neuralgia

0 Actively Recruiting

Gilles de la Tourette's Syndrome

0 Actively Recruiting

clozapine

0 Actively Recruiting

Defiant Disorder, Oppositional

6 Actively Recruiting

Not Applicable

Smoking Cessation

97 Actively Recruiting

Early Phase 1, Phase 2, Phase 4, Not Applicable, Phase 1, Phase 3

Human Growth Hormone Deficiency

7 Actively Recruiting

Phase 3, Phase 2, Phase 4

Hypertensive disease

19 Actively Recruiting

Not Applicable, Phase 1, Phase 2, Phase 3

Hot flashes

22 Actively Recruiting

Phase 2, Not Applicable, Phase 1, Phase 4, Early Phase 1

Hot Flashes

14 Actively Recruiting

Phase 3, Not Applicable, Phase 2

clonidine suppression test

0 Actively Recruiting

Kapvay Reviews: What are patients saying about Kapvay?

5Patient Review

11/19/2011

Kapvay for Attention Deficit Disorder with Hyperactivity

This treatment has been great for my daughter. She's four years old and was diagnosed with ADHD, so she takes Kapvay and risperidone twice a day. They both work well and help her stay focused and calm throughout the day. It was hard to get her to take the pills at first, but after a while she was able to do it on her own and even tells me when it is time to take them.

5Patient Review

1/12/2012

Kapvay for "Change of Life" Signs

This drug has been a game-changer for my five-year-old. She's been sleeping through the night since we started using it six months ago.

3.7Patient Review

11/14/2012

Kapvay for Attention Deficit Disorder with Hyperactivity

My son is 12 years old. He is Autistic, ODD, ADHD and Bi-polar. This medication was suppose to treat the impulsive rage that he has. It helped at first, but after the second week, it stopped working. My doctor just decided to change drugs due to how intense my son's 'freak out' moments were getting. The drug did work very well at first-- for a full two days we had NO drama!!! That was a welcomed blessing from above!

3Patient Review

7/17/2012

Kapvay for Attention Deficit Disorder with Hyperactivity

My daughter didn't seem to concentrate or focus any better on this medication, and it was quite expensive to maintain the prescribed dosage. She did have fewer upper respiratory infections, however.

2.3Patient Review

5/28/2013

Kapvay for Attention Deficit Disorder with Hyperactivity

If your child has accidentally taken a double dose of this medication, it's important to seek professional medical advice right away.

Patient Q&A Section about kapvay

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is Kapvay prescribed for?

"This drug is used to treat ADHD by itself or with other drugs as part of a comprehensive treatment plan that also includes psychological and social therapies, among other treatments."

Answered by AI

Is Kapvay the same as clonidine?

"Both Kapvay and Catapres contain the drug clonidine. The doses of the two drugs are usually similar. However, Kapvay is used to treat ADHD, while Catapres is used to treat high blood pressure. Catapres is available as an immediate-release tablet, while Kapvay is available as an extended-release tablet."

Answered by AI

How does Kapvay work for ADHD?

"The drug Kapvay works by targeting alpha-2 receptors in the brain in order to potentially reduce symptoms of hyperactivity by altering the way the brain processes emotions, attention, and behavior. While the method by which this drug treats ADHD is not known for certain, the FDA approved its use for pediatric patients aged 6-17 in September of 2010."

Answered by AI

Is Kapvay a stimulant?

"Kapvay is a prescription medicine that is used to treat attention deficit hyperactivity disorder (ADHD). It is supplied as an extended-release tablet. Your doctor may prescribe Kapvay alone or together with other ADHD medicines. Kapvay is not a central nervous system (CNS) stimulant."

Answered by AI

Clinical Trials for Kapvay

Image of The University of Texas health Science Center at Houston in Houston, United States.

Bupropion +1 More for Smoking Cessation

This trial aims to test if giving a combination of injectable naltrexone and oral bupropion to individuals with schizophrenia who smoke cigarettes is safe and possible. They will also look at how

Waitlist Available

The University of Texas health Science Center at HoustonJin H Yoon, PhD

Image of Centre for Addiction and Mental Health in Toronto, Canada.

Behavioral Parent Training for Conduct Disorder

Toronto, Canada

"This trial will create individual profiles for children with Disruptive Behaviour Disorder and their parents, using psychological, emotional, and neuropsychological factors. These profiles will help predict how they will respond to a

Centre for Addiction and Mental HealthBrendan F. Andrade, PhD

Image of Tufts University in Boston, United States.

Food is Medicine for Cardiometabolic Risk Factors

This trial focuses on improving the health of residents in the Mississippi Delta, who have faced food insecurity and poverty due to historical factors. The project aims to provide a "Food is Medicine" intervention through distributing

Waitlist Available

Tufts UniversityChristina D Economos, PhD

Image of Cincinnati Children's Hospital Medical Center in Cincinnati, United States.

Personalized ADHD Medication Experiment for Attention Deficit Hyperactivity Disorder (ADHD)

This trial aims to test personalized medication experiments to help make decisions about future medication use for adolescents. The researchers believe that their intervention will increase the adolescents' involvement in decision making and reduce uncertainty about future medication

Cincinnati Children's Hospital Medical CenterWilliam Brinkman, MD, MEd, MSc

Have you considered Kapvay clinical trials? We made a collection of clinical trials featuring Kapvay, we think they might fit your search criteria.

Explore trials for Kapvay

Image of University of Colorado Anschutz Medical Campus in Aurora, United States.

Transdermal Estradiol Patch +2 More for Menopause

"This trial aims to study how the decrease in estrogen during menopause affects artery health and body fat distribution in women. The researchers will investigate whether low estrogen levels lead to decreased artery function and increased fat in

Waitlist Available

University of Colorado Anschutz Medical CampusKerrie Moreau, PhD

Image of University of California Berkeley in Berkeley, United States.

UC-A +1 More for Attention Deficit Hyperactivity Disorder (ADHD)

"This trial aims to see if using mobile apps can help improve cognitive function and reduce symptoms in adults with ADHD."

University of California Berkeley (+1 Sites)Robert Bilder, Ph.DThink Now Incorporated

Image of Medical University of South Carolina in Charleston, United States.

Smoking cessation e-visit for Smoking Cessation

This trial is testing an online questionnaire program to help people with COPD quit smoking. Participants will be randomly assigned to receive the program or not. The program will ask about smoking history, preferences for quitting

Waitlist Available

Medical University of South Carolina

Image of UW Carbone Cancer Center in Madison, United States.

Varenicline for Smoking Cessation

This trial will compare two different ways to help cancer patients quit smoking. One group will receive 12 weeks of varenicline treatment and coaching calls focused on quitting smoking with cancer. The other group

Waitlist Available

UW Carbone Cancer CenterDanielle E McCarthy, PhD

Have you considered Kapvay clinical trials? We made a collection of clinical trials featuring Kapvay, we think they might fit your search criteria.

Explore trials for Kapvay

Image of University of California, San Francisco in San Francisco, United States.

Beta testing (CONNECTing to LungCare, feedback) for Smoking Cessation

San Francisco, CA

This trial is testing a program called CONNECTing to LungCare, which aims to improve conversations between patients and healthcare providers about quitting smoking and getting screened for lung cancer. The program includes education and tools to

Waitlist Available

University of California, San FranciscoJudith Walsh-Cassidy, MDAlere San Diego

Image of Hybl Sports Medicine and Performance Center in Colorado Springs, United States.

Hot Water Therapy for Menopause

Colorado Springs, CO

This trial is studying the effects of hot water therapy on menopausal women. The researchers want to see if taking hot baths for multiple days in a row can reduce hot flash symptoms and improve mood.

Hybl Sports Medicine and Performance CenterNathan Morris, PhD

Image of Mayo Clinic Hospital Methodist in Rochester, United States.

tRNS for Attention Deficit Hyperactivity Disorder (ADHD)

This trial is investigating the safety and effectiveness of a treatment called tRNS on children with ADHD who are not taking medication. The children will either receive the tRNS treatment or a fake treatment for

Waitlist Available

Mayo Clinic Hospital Methodist (+4 Sites)Paul CroarkinInnosphere

Image of Brigham and Women's Hospital in Boston, United States.

Time-restricted Eating for Menopause

This trial aims to see how restricting eating to only an 8-hour window each day affects the levels of fats in the blood and the composition of the body in women who are going through or have recently

Brigham and Women's HospitalLeilah K Grant, PhD

Have you considered Kapvay clinical trials? We made a collection of clinical trials featuring Kapvay, we think they might fit your search criteria.

Explore trials for Kapvay

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

Back to top

Terms of Service Privacy Policy Security